Results 231 to 240 of about 289,251 (304)

Safe Supply at Insite, North America's First Supervised Consumption Site: A Case Report of Reduced Harms From the Toxic Drug Supply in a Client Prescribed Powdered Fentanyl Alternative. [PDF]

Drug Alcohol Rev
Fairbairn N, Hu E, Lysyshyn M, Brar R, Holliday E.   +4 more
europepmc   +1 more source

The real-world safety evaluation of the selective NaV1.8 inhibitor suzetrigine: disproportionality analysis and flexible empirical bayes signals from FAERS with external triangulation. [PDF]

Front Pharmacol
Lai K, Luo L, Zhang F, Tan ESS, Gaurav A, Zheng J, Tan CK.   +6 more
europepmc   +1 more source

The Cannabis Research Image Database (CRESIDA): A standardized and validated image set for studying cannabis cue reactivity

Addiction, EarlyView.
Abstract Background and aims Cannabis cue reactivity paradigms are instrumental in studying the behavioral and neurocognitive mechanisms of cannabis use and cannabis use disorders; however, image sets used for cannabis cue reactivity paradigms vary between studies, and the lack of reliability and validity assessment hinders the quality of evidence they
Janna Cousijn, Emese Kroon, Chao Suo, Tom P. Freeman, Chandni Hindocha, Marianna Quinones‐Valera, Valentina Lorenzetti   +6 more
wiley   +1 more source

Examining the relationship between opioid use and symptom-defined obstructive sleep apnea and sleep duration: A cross-sectional study. [PDF]

Medicine (Baltimore)
Li C, Mei Y, Xie P, Lu T, Huang J, Zhao Z.   +5 more
europepmc   +1 more source

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source

Comparative risk of psychiatric comorbidities associated with codeine and tramadol in patients with hip osteoarthritis: a nationwide population-based cohort study. [PDF]

J Glob Health
Kim Y, Choo E, Shin S, Choi YJ.
europepmc   +1 more source

Prevalence and associated factors of opioid-related disorders among patients with chronic pain: a single-center retrospective study in a Chinese tertiary hospital

BMC Anesthesiology
Zhiyan Xu, Cheng Si, Yinling Dong, Hang Zhang, Jinyuan Zhang, Weihong Ge, Xiaoyan Wu   +6 more
openaire   +1 more source

Craving and personal functioning as mediators of extended‐release buprenorphine efficacy: A four‐way decomposition analysis from a randomised trial

Addiction, EarlyView.
Abstract Aims To investigate whether the treatment effect of extended‐release buprenorphine (BUP‐XR) on opioid‐free days in opioid use disorder (OUD) is mediated by reductions in opioid craving and improvements in personal functioning. Design and setting Exploratory causal mediation analysis using VanderWeele's four‐way decomposition framework in a 24 ...
John Marsden, Mike Kelleher, Fiona Cowden, Edward Day, Jonathan Dewhurst, Rachel Evans, Eilish Gilvarry, Natalie Lowry, Luke Mitcheson, Robert Murray, Sophie Quarshie, Zoë Hoare   +11 more
wiley   +1 more source

Why are Massachusetts opioid prescribing rates higher in rural versus urban areas? [PDF]

PLoS One
Modestino AS, Young GJ, Hasan MM, Shi J, Alam MNE.   +4 more
europepmc   +1 more source

Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations [PDF]

, 2011
Liang, Wei-Jun, Pounder, Derrick, Bunten, Hannah, Osselton, David M.   +3 more
core